![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/48 | |
A61K 8/99 | |||
A61K 9/00 | |||
A61K 47/26 | |||
A61Q 7/00 | |||
A61Q 19/08 | |||
A61P 1/00 | |||
A61P 5/00 | |||
A61P 11/00 | |||
A61P 13/00 | |||
A61P 17/00 | |||
A61P 21/00 | |||
A61P 25/14 | |||
A61P 27/00 | |||
A61P 29/00 | |||
A61P 37/00 |
(11) | Patento numeris | 2813239 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 14180875.8 |
Europos patento paraiškos padavimo data | 2005-08-03 | |
(97) | Europos patento paraiškos paskelbimo data | 2014-12-17 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-22 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
0417367 | 2004-08-04 | GB | |
0421290 | 2004-09-24 | GB | |
0421288 | 2004-09-24 | GB | |
0423952 | 2004-10-28 | GB | |
0423953 | 2004-10-28 | GB |
(72) |
Panjwani, Naveed, GB
Webb, Paul, GB
Pickett, Andrew, GB
|
(73) |
Ipsen Biopharm Limited,
Ash Road Wrexham Industrial Estate, Clwyd LL13 9UF,
GB
|
(54) | Pharmaceutical composition containing botulinum neurotoxin A2 |
Pharmaceutical composition containing botulinum neurotoxin A2 |